During the past decade, Saddleback Memorial Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saddleback Memorial Medical Center" #1 sponsor was "Obstetrix Medical Group" with 6 trials, followed by "Alexion" with 1 trials sponsored, "City of Hope Medical Center" with 1 trials sponsored, "Critical Therapeutics" with 1 trials sponsored and "Cubist Pharmaceuticals LLC" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saddleback Memorial Medical Center" #1 collaborator was "Genomic Health®, Inc." with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Saddleback Memorial Medical Center" are "Preterm Delivery" (2 trials), "Acute Myocardial Infarction" (1 trials), "Acute Pain" (1 trials), "Anesthesia" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Saddleback Memorial Medical Center" in a lesser frequency.

Most popular intervention types in "Saddleback Memorial Medical Center" are "Drug" (12 trials), "Procedure" (2 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "17-alpha-hydroxyprogesterone caproate injectable" (1 trials), "AQUAVAN® (fospropofol disodium) Injection" (1 trials), "Alvimopan" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saddleback Memorial Medical Center" are 11 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Saddleback Memorial Medical Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Saddleback Memorial Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Saddleback Memorial Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".